AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL
· Real-Time Price · USD
4.58
0.08 (1.78%)
At close: Aug 15, 2025, 3:59 PM
4.61
0.66%
After-hours: Aug 15, 2025, 07:54 PM EDT
AbCellera Biologics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 4.24M | 5.05M | 6.51M | 7.32M | 9.95M | 9.18M | 6.6M | 10.06M | 12.19M | 21.55M | 101.38M | 45.92M | 316.58M | 139.33M | 5.51M | 27.64M | 202.74M |
Cost of Revenue | 42.5M | 13.9M | 38.3M | 38.04M | 6.77M | 9.11M | 7.41M | 7.26M | 52.65M | 1.55M | 15.04M | 5.21M | 44.64M | 21.89M | 17.45M | 3.61M | 20.01M |
Gross Profit | -38.26M | -8.85M | -31.79M | -30.71M | 3.19M | 70K | -810K | 2.8M | -40.45M | 19.99M | 86.35M | 40.71M | 271.94M | 117.44M | -11.94M | 24.03M | 182.73M |
Operating Income | -105.16M | -72.75M | -93.66M | -93.45M | -54.89M | -66.05M | -54.89M | -51.39M | -61.5M | -37.78M | 37.73M | -6.86M | 224.95M | 81.55M | -28.1M | -7.03M | 158.07M |
Interest Income | n/a | 8.67M | 9.6M | 9.8M | 10.4M | 10.97M | 10.74M | 10.78M | 9.76M | n/a | 5.56M | 1.41M | 665K | n/a | n/a | n/a | n/a |
Pretax Income | -52.98M | -46.83M | -62.63M | -48.19M | -42.75M | -48.6M | -39.28M | -38M | -48.15M | -31.41M | 46.59M | -6.89M | 230.81M | 84.71M | -24.97M | -2.07M | 161.49M |
Net Income | -45.62M | -34.21M | -51.11M | -36.93M | -40.61M | -47.15M | -28.61M | -30.53M | -40.11M | -29.89M | 26.62M | -6.79M | 168.57M | 59.95M | -21.38M | -2.32M | 117.22M |
Selling & General & Admin | 19.07M | 19.16M | 22.28M | 23.33M | 20.72M | 19.07M | 17.84M | 19.36M | 18.91M | 15.71M | 16.88M | 17.53M | 16.64M | 14.72M | 12.49M | 12.5M | 9M |
Research & Development | 42.5M | 46.08M | 40.97M | 40.93M | 39.29M | 48.62M | 37.92M | 36.47M | 52.65M | 28.25M | 26.58M | 26.68M | 26.37M | 17.21M | 17.45M | 15.05M | 12.35M |
Other Expenses | 5.33M | 12.56M | 36.92M | 32.16M | -1.53M | 3.11M | 2.05M | -1.97M | 2.14M | 13.82M | 3M | 3.35M | -1.2M | -1.35M | -1.26M | 314K | 265K |
Operating Expenses | 66.89M | 77.81M | 100.17M | 62.74M | 58.08M | 71.86M | 58.66M | 56.87M | 73.69M | 57.77M | 46.46M | 47.57M | 41.8M | 30.57M | 29.22M | 26.42M | 21.51M |
Interest Expense | 8.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 2.84M | 3.14M | 3.13M | 3.14M | 3.37M | 3.1M | 3.47M | 3.84M | 3.77M | 2.69M | 3.09M | 3.12M | 2.37M | 1.83M | 1.22M | 1.29M | 2.58M |
Cost & Expenses | 109.39M | 77.81M | 100.17M | 100.78M | 64.85M | 71.86M | 58.66M | 56.87M | 73.69M | 59.32M | 61.5M | 52.78M | 86.44M | 52.47M | 29.22M | 30.03M | 41.52M |
Income Tax Expense | -7.36M | -12.62M | -11.53M | -11.26M | -2.14M | -1.45M | -10.67M | -7.48M | -8.04M | -1.52M | 19.96M | -101K | 62.24M | 24.76M | -3.59M | 250K | 44.27M |
Shares Outstanding (Basic) | 297.69M | 295.76M | 294.85M | 294.22M | 292.72M | 290.05M | 289.5M | 288.91M | 287.77M | 286.41M | 315.82M | 284.69M | 311.48M | 278.93M | 267.25M | 272.2M | 269.7M |
Shares Outstanding (Diluted) | 297.69M | 295.76M | 294.85M | 294.22M | 292.72M | 290.05M | 289.5M | 288.91M | 287.77M | 301.3M | 315.82M | 284.69M | 311.48M | 278.93M | 278.93M | 272.2M | 320.28M |
EPS (Basic) | -0.15 | -0.12 | -0.17 | -0.13 | -0.14 | -0.16 | -0.1 | -0.11 | -0.14 | -0.1 | 0.08 | -0.02 | 0.54 | 0.21 | -0.08 | -0.01 | 0.43 |
EPS (Diluted) | -0.15 | -0.12 | -0.17 | -0.13 | -0.14 | -0.16 | -0.1 | -0.11 | -0.14 | -0.1 | 0.08 | -0.02 | 0.54 | 0.21 | -0.08 | -0.01 | 0.37 |
EBITDA | -39.6M | -55.31M | -51.88M | -56.93M | -48.13M | -58.52M | -44.65M | -39.56M | -59.36M | -4.66M | 53.31M | -845K | 235.78M | 94.8M | -20.77M | 2.14M | 165.45M |
EBIT | -44.93M | -47.63M | -90.17M | -90.14M | -51.62M | -62.68M | -52.06M | -46.81M | -61.5M | -20.02M | 37.73M | -6.86M | 224.95M | 81.55M | -24.97M | -2.39M | 158.07M |
Depreciation & Amortization | 5.33M | 13.9M | 38.3M | 38.04M | 6.77M | 9.11M | 7.41M | 7.26M | 7.12M | 15.36M | 6.73M | 6.04M | 4.97M | 4.86M | 4.21M | 4.21M | 3.97M |